Arcturus Therapeutics Holdings (ARCT) Current Taxes (2022 - 2024)
Arcturus Therapeutics Holdings' (ARCT) quarterly Current Taxes came in at $979000.0 in Q1 2024, down 29.97% YoY from $1.4 million in Q2 2023, and up 52.73% on a QoQ basis from $641000.0 in Q4 2023.
Analysis
Arcturus Therapeutics Holdings (ARCT) Current Taxes (2022 - 2024) Analysis & Trends
Arcturus Therapeutics Holdings (ARCT) has 3 years of Current Taxes data on file, last reported at $979000.0 in Q1 2024.
- Quarterly Current Taxes fell 29.97% year-over-year to $979000.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $979000.0 (down 29.97% YoY) and the FY2023 annual result came in at $641000.0, down 50.5% from the prior year.
- Current Taxes improved to $979000.0 in Q1 2024, from $641000.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $1.4 million in Q1 2023 to a low of $482000.0 in Q3 2023.
- A 3-year average of $959000.0 and a median of $979000.0 in 2024 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2023 — Current Taxes tumbled 50.5% — and 2024, when it fell 29.97%.
- Tracing ARCT's Current Taxes over 3 years: stood at $1.3 million in 2022, then plunged by 50.5% to $641000.0 in 2023, then surged by 52.73% to $979000.0 in 2024.
- The last three Current Taxes figures came in at $979000.0 (Q1 2024), $641000.0 (Q4 2023), and $482000.0 (Q3 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 76.32 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Arcturus Therapeutics Holdings | 449.65 Mn | 258.17 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 979,000.00 |
| Dec 31, 2023 | 641,000.00 |
| Sep 30, 2023 | 482,000.00 |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | 1.30 Mn |